Clinical Trials Directory

Trials / Completed

CompletedNCT02456337

Xenogenous Collagen Matrix Graft With or Without Enamel Matrix Proteins Derivative for Root Coverage

Xenogenous Collagen Matrix Graft Associated or Not With Enamel Matrix Derivative Proteins in the Treatment of Gingival Recession Class I and II of Miller: Randomized Controlled Clinical Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
49 (actual)
Sponsor
University of Campinas, Brazil · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the reduction of gingival recession of single Miller Class I and II defects treated by coronally advanced flap with subepithelial porcine collagen matrix graft and / or enamel matrix proteins.

Conditions

Interventions

TypeNameDescription
DEVICEMucograftCoronally advanced flap associated to Xenogenous collagen matrix graft (mucograft) for the treatment of gingival recessions Miller Class I or II.
DEVICEEmdogainCoronally advanced flap associated to Enamel Matrix Derivative (Emdogain) for the treatment of gingival recessions Miller Class I or II.
PROCEDURECoronally Advanced flapCoronally advanced flap for the treatment of gingival recessions Miller Class I or II.

Timeline

Start date
2014-07-01
Primary completion
2016-09-01
Completion
2016-10-01
First posted
2015-05-28
Last updated
2016-10-27

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02456337. Inclusion in this directory is not an endorsement.